» Articles » PMID: 8924586

Inhibition of Thyroid Peroxidase by Dietary Flavonoids

Overview
Specialty Toxicology
Date 1996 Jan 1
PMID 8924586
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Flavonoids are widely distributed in plant-derived foods and possess a variety of biological activities including antithyroid effects in experimental animals and humans. A structure-activity study of 13 commonly consumed flavonoids was conducted to evaluate inhibition of thyroid peroxidase (TPO), the enzyme that catalyzes thyroid hormone biosynthesis. Most flavonoids tested were potent inhibitors of TPO, with IC50 values ranging from 0.6 to 41 microM. Inhibition by the more potent compounds, fisetin, kaempferol, naringenin, and quercetin, which contain a resorcinol moiety, was consistent with mechanism-based inactivation of TPO as previously observed for resorcinol and derivatives. Other flavonoids inhibited TPO by different mechanisms, such as myricetin and naringin, showed noncompetitive inhibition of tyrosine iodination with respect to iodine ion and linear mixed-type inhibition with respect to hydrogen peroxide. In contrast, biochanin A was found to be an alternate substrate for iodination. The major product, 6,8-diiodo-biochanin A, was characterized by electrospray mass spectrometry and 1H-NMR. These inhibitory mechanisms for flavonoids are consistent with the antithyroid effects observed in experimental animals and, further, predict differences in hazards for antithyroid effects in humans consuming dietary flavonoids. In vivo, suicide substrate inhibition, which could be reversed only by de novo protein synthesis, would be long-lasting. However, the effects of reversible binding inhibitors and alternate substrates would be temporary due to attenuation by metabolism and excretion. The central role of hormonal regulation in growth and proliferation of thyroid tissue suggests that chronic consumption of flavonoids, especially suicide substrates, could play a role in the etiology of thyroid cancer.

Citing Articles

A 2024 inventory of test methods relevant to thyroid hormone system disruption for human health and environmental regulatory hazard assessment.

Vergauwen L, Bajard L, Tait S, Langezaal I, Sosnowska A, Roncaglioni A Open Res Eur. 2025; 4:242.

PMID: 39931575 PMC: 11809485. DOI: 10.12688/openreseurope.18739.1.


Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment.

Huang W, Jiang T, He J, Ruan J, Wu B, Tao R Probiotics Antimicrob Proteins. 2025; .

PMID: 39890752 DOI: 10.1007/s12602-025-10471-z.


Quercetin and Thyroid.

Giuliani C, Di Dalmazi G, Bucci I, Napolitano G Antioxidants (Basel). 2024; 13(10).

PMID: 39456456 PMC: 11505551. DOI: 10.3390/antiox13101202.


Pharmacological and mechanistic aspects of quercetin in osteoporosis.

Deng T, Ding W, Lu X, Zhang Q, Du J, Wang L Front Pharmacol. 2024; 15:1338951.

PMID: 38333006 PMC: 10851760. DOI: 10.3389/fphar.2024.1338951.


Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis.

Szukiewicz D Int J Mol Sci. 2023; 24(15).

PMID: 37569571 PMC: 10418522. DOI: 10.3390/ijms241512195.